RTW INVESTMENTS, LP Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$379.9B
Holdings
28
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALNYAlnylam Pharmaceuticals Inc | 1,092,516 | $56.0B | 14.74% | |
| 2 | —Avexis Inc | 623,330 | $47.4B | 12.47% | |
| 3 | BMYBristol-Myers Squibb Co | 570,692 | $31.0B | 8.17% | |
| 4 | —La Jolla Pharmaceutical Co | 1,028,929 | $30.7B | 8.08% | |
| 5 | BCRXBioCryst Pharmaceuticals Inc | 3,458,120 | $29.0B | 7.65% | |
| 6 | —Medicines Co | 572,689 | $28.0B | 7.37% | |
| 7 | RGNXRegenxbio Inc | 1,216,505 | $23.5B | 6.18% | |
| 8 | ATRAGBXAtara Biotherapeutics Inc | 908,733 | $18.7B | 4.92% | |
| 9 | AGENEURAgenus Inc | 4,245,882 | $16.0B | 4.21% | |
| 10 | PTCTPTC Therapeutics Inc | 1,305,643 | $12.8B | 3.38% | |
| 11 | INCYIncyte Corp | 82,490 | $11.0B | 2.90% | |
| 12 | —Oxford Immunotec Global PLC | 612,903 | $9.5B | 2.50% | |
| 13 | —bluebird bio Inc | 103,617 | $9.4B | 2.48% | |
| 14 | 3M4Masimo Corp | 80,900 | $7.5B | 1.99% | |
| 15 | EP3OraSure Technologies Inc | 566,230 | $7.3B | 1.93% | |
| 16 | —Viveve Medical Inc | 1,145,736 | $7.3B | 1.91% | |
| 17 | —Dicerna Pharmaceuticals Inc | 2,062,991 | $7.0B | 1.85% | |
| 18 | —Corium International Inc | 1,448,991 | $6.1B | 1.59% | |
| 19 | TCMDTactile Systems Technology Inc | 287,876 | $5.5B | 1.44% | |
| 20 | I9DNArbutus Biopharma Corp | 1,446,587 | $4.7B | 1.24% | |
| 21 | VRAYQViewray Inc | 515,612 | $4.4B | 1.16% | |
| 22 | —Invuity Inc | 470,167 | $3.7B | 0.98% | |
| 23 | GBTUSDGlobal Blood Therapeutics Inc | 26,183 | $965.0M | 0.25% | |
| 24 | —Celldex Therapeutics Inc | 241,699 | $873.0M | 0.23% | |
| 25 | —Biopharmx Corp | 1,283,951 | $648.0M | 0.17% | |
| 26 | SRTSSensus Healthcare Inc | 90,404 | $397.0M | 0.10% | |
| 27 | NTRANatera Inc | 31,693 | $281.0M | 0.07% | |
| 28 | —Sensus Heatlhcare Inc | 155,000 | $136.0M | 0.04% |